88 related articles for article (PubMed ID: 12613406)
21. In vivo effect of losartan on platelet aggregation in patients with hypertension.
Akdemir R; Ozhan H; Yazici M; Gunduz H; Duran S; Gurel C; Ozdas S; Uyan C; Basar I; Ulutin T
Heart Vessels; 2004 Jul; 19(4):167-71. PubMed ID: 15278389
[TBL] [Abstract][Full Text] [Related]
22. The mean platelet volume in patients with essential and white coat hypertension.
Coban E; Yazicioglu G; Berkant Avci A; Akcit F
Platelets; 2005 Nov; 16(7):435-8. PubMed ID: 16236605
[TBL] [Abstract][Full Text] [Related]
23. Serum nitric oxide metabolite (NO(x)) levels in hypertensive patients at rest: a comparison of age, gender, blood pressure and complications using normotensive controls.
Higashino H; Miya H; Mukai H; Miya Y
Clin Exp Pharmacol Physiol; 2007 Aug; 34(8):725-31. PubMed ID: 17600548
[TBL] [Abstract][Full Text] [Related]
24. Utility of a whole blood single platelet counting assay to monitor the effects of tirofiban in patients with acute coronary syndromes scheduled for coronary intervention.
Siotia A; Buckland R; Judge HM; Sastry P; Storey RF
Thromb Haemost; 2006 Jun; 95(6):997-1002. PubMed ID: 16732379
[TBL] [Abstract][Full Text] [Related]
25. Follow-up of hemorheological parameters and platelet aggregation in patients with acute coronary syndromes.
Marton Z; Horvath B; Alexy T; Kesmarky G; Gyevnar Z; Czopf L; Habon T; Kovacs L; Papp E; Mezey B; Roth E; Juricskay I; Toth K
Clin Hemorheol Microcirc; 2003; 29(2):81-94. PubMed ID: 14610303
[TBL] [Abstract][Full Text] [Related]
26. Amlodipine in hypertension: its effects on platelet aggregation and dynamic exercise.
Hernández R; Carvajal AR; Armas-de Hernande MJ; Guerrero-Pajuelo J; Armas-Padilla MC; Barragan O; Machado-de Alvarado I
J Cardiovasc Pharmacol; 1991; 17 Suppl 1():S25-7. PubMed ID: 16296703
[TBL] [Abstract][Full Text] [Related]
27. Increased platelet sensitivity among individuals with aspirin resistance - platelet aggregation to submaximal concentration of arachidonic acid predicts response to antiplatelet therapy.
Guthikonda S; Mangalpally K; Vaduganathan M; Patel R; Delao T; Bergeron AL; Dong JF; Lev EI; Kleiman NS
Thromb Haemost; 2008 Jul; 100(1):83-9. PubMed ID: 18612542
[TBL] [Abstract][Full Text] [Related]
28. Circulating homocysteine levels in sustained and white coat hypertension.
Pierdomenico SD; Bucci A; Lapenna D; Lattanzio FM; Talone L; Cuccurullo F; Mezzetti A
J Hum Hypertens; 2003 Mar; 17(3):165-70. PubMed ID: 12624606
[TBL] [Abstract][Full Text] [Related]
29. [Hemorheological alterations in hypertensive patients].
Foresto P; D'Arrigo M; Filippini F; Gallo R; Barberena L; Racca L; Valverde J; Rasia RJ
Medicina (B Aires); 2005; 65(2):121-5. PubMed ID: 16075805
[TBL] [Abstract][Full Text] [Related]
30. Acute water ingestion increases arterial blood pressure in hypertensive and normotensive subjects.
Callegaro CC; Moraes RS; Negrão CE; Trombetta IC; Rondon MU; Teixeira MS; Silva SC; Ferlin EL; Krieger EM; Ribeiro JP
J Hum Hypertens; 2007 Jul; 21(7):564-70. PubMed ID: 17344908
[TBL] [Abstract][Full Text] [Related]
31. Assessment of platelet activation indices using the ADVIATM 120 amongst 'high-risk' patients with hypertension.
Boos CJ; Beevers GD; Lip GY
Ann Med; 2007; 39(1):72-8. PubMed ID: 17364453
[TBL] [Abstract][Full Text] [Related]
32. Blood pressure variability and arterial elasticity in hypertensive subjects.
Rafidah HM; Azizi A; Noriah MN
Med J Malaysia; 2006 Jun; 61(2):189-98. PubMed ID: 16898310
[TBL] [Abstract][Full Text] [Related]
33. Clopidogrel anti-platelet effect: an evaluation by optical aggregometry, impedance aggregometry, and the platelet function analyzer (PFA-100).
Dyszkiewicz-Korpanty A; Olteanu H; Frenkel EP; Sarode R
Platelets; 2007 Nov; 18(7):491-6. PubMed ID: 17852774
[TBL] [Abstract][Full Text] [Related]
34. Tissue factor expression and activity are not increased in peripheral monocytes isolated from uncomplicated hypertensive patients.
Sardo MA; Campo S; Castaldo M; Bonaiuto A; Bitto A; Saitta C; Cristadoro S; Trimarchi G; Saitta A
J Hypertens; 2006 Apr; 24(4):731-6. PubMed ID: 16531802
[TBL] [Abstract][Full Text] [Related]
35. Increased platelet cholesterol and decreased percentage volume of platelets as a secondary risk factor for coronary artery disease.
Ravindran R; Krishnan LK
Pathophysiol Haemost Thromb; 2007; 36(1):45-51. PubMed ID: 18332614
[TBL] [Abstract][Full Text] [Related]
36. Relationship between high platelet turnover and platelet function in high-risk patients with coronary artery disease on dual antiplatelet therapy.
Cesari F; Marcucci R; Caporale R; Paniccia R; Romano E; Gensini GF; Abbate R; Gori AM
Thromb Haemost; 2008 May; 99(5):930-5. PubMed ID: 18449424
[TBL] [Abstract][Full Text] [Related]
37. Platelet function and hypertension in humans.
Fleischman AI; Comberg HU; Hames CG
J Med Soc N J; 1979 Jan; 76(1):17-20. PubMed ID: 284145
[No Abstract] [Full Text] [Related]
38. [Unilateral adrenal hemorrhage and hypertensive crisis in a patient with antiplatelet treatment].
Maciá Babes C; Macías Rables MD; Ronzón Fernández A; Botas Cervero P; López Díaz Mdel V; Municio Heras AI
Arch Esp Urol; 2007 Nov; 60(9):1.119-22. PubMed ID: 18077868
[TBL] [Abstract][Full Text] [Related]
39. [Routine platelet aggregation inhibition not useful when using acetylsalicylic acid or clopidogrel].
Kramer MC; Nieuwland R; Sturk A; de Winter RJ
Ned Tijdschr Geneeskd; 2009 Jan; 153(5):190-5. PubMed ID: 19256247
[No Abstract] [Full Text] [Related]
40. Aspirin therapy as primary prevention in hypertensive patients at Srinagarind hospital.
Sawanyawisuth K; Limpawattana P; Bumrerraj S; Thongmee A; Kosakarn J; Choenrungroj T; Pradit P; Naranunn P; Punyamee S; Premgamone A
J Med Assoc Thai; 2005 Dec; 88(12):1797-801. PubMed ID: 16518976
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
